HGH Fragment 176-191 and Retatrutide Interaction

Monitor
Mechanism-based 47% confidence

HGH Fragment 176-191 and Retatrutide have an interaction requiring monitoring for interaction with 47% confidence. Both HGH Fragment 176-191 and Retatrutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

HGH Fragment 176-191

Growth Hormone Fragment | Fat Loss Peptide

Mimics the lipolytic region of human growth hormone by stimulating fat breakdown through beta-3 adrenergic receptor pathways. Unlike full HGH, it does not bind the growth hormone receptor, so it does not increase IGF-1 levels or interfere with glucose metabolism.

Half-life: 15-20 minutes Typical dose: 250-500mcg weight loss, metabolic
carcinogenic riskinsulin disruptingteratogenic
View full profile

Retatrutide

Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes

Activates GLP-1 for appetite suppression, GIP for insulin sensitivity, and glucagon for increased energy expenditure and hepatic fat oxidation..

Half-life: ~6 days Typical dose: 0.5mg starting, titrate up to 8-12mg weekly weight loss, metabolic
insulin disrupting
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (HGH Fragment 176-191, Retatrutide). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take HGH Fragment 176-191 with Retatrutide?

Yes, but with caution. Both HGH Fragment 176-191 and Retatrutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is HGH Fragment 176-191 and Retatrutide safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between HGH Fragment 176-191 and Retatrutide?

Both HGH Fragment 176-191 and Retatrutide affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time HGH Fragment 176-191 and Retatrutide?

HGH Fragment 176-191 has a half-life of 15-20 minutes and Retatrutide has a half-life of ~6 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: HGH Fragment 176-191 vs Retatrutide

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.